More recently, various cytokine protocols have been shown to effectively stimulate CLL patient NK cells in vitro, including IL-2, IL-15, IL-21, IL-12 + IL-15, and IL-2 + IL-18 [91,93,96,97,98,258]. This evidence concerns the gene IL2 and B-cell chronic lymphocytic leukemia.